Malaria

More from the Series

WORKING PAPER

Malaria Case Management After the Affordable Medicines Facility for Malaria (AMFm): Availability, Quality, and Market Share for ACTs in Kenya’s Private Pharmacies
Daniel Rosen et al.
December 14, 2020
Between 2011 and 2016, the Affordable Medicines Facility-Malaria (AMFm) subsidy program substantially increased access to WHO prequalified artemisinin combination therapies (ACTs) through Africa’s private sector pharmacies and drug-sellers. While the program was rigorously and extensively evaluated,...
WORKING PAPER

Does Deforestation Increase Malaria Prevalence? Evidence from Satellite Data and Health Surveys - Working Paper 480
Sebastian Bauhoff
and
Jonah Busch
March 22, 2018
In this paper we combine fourteen years of high-resolution satellite data on forest loss with individual-level survey data on malaria in more than 60,000 rural children in 17 countries in Africa, and fever in more than 470,000 rural children in 41 countries in Latin America, Africa, and Asia. W...
Blog Post

Does Deforestation Increase Malaria Rates? Not in Africa, We’re Surprised to Find
Sebastian Bauhoff
and
Jonah Busch
March 22, 2018
Deforestation isn’t associated with higher malaria prevalence in children in 17 African countries. Nor is it associated with higher fever in children in 41 countries across Africa, Asia, and Latin America. That’s the surprising conclusion of our new CGD working paper.
Blog Post

Rigorous Evidence Shows US Global Health Efforts Work. Come Hear About It at CGD!
Amanda Glassman et al.
September 15, 2017
Clear and rigorous evidence on the contributions of US global health programs is more important than ever, as the White House and lawmakers discuss and debate budgets and the future of US support to global health. Such information aids policymakers who must prioritize support to effective public hea...